Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 26, 2013, Pages

  Knutson, Charles G ^a   Mangerich, Aswin ^a,b   Zeng, Yu ^a   Raczynski, Arkadiusz R ^a   Liberman, Rosa G ^a   Kang, Pilsoo ^a   Ye, Wenjie ^a   Prestwich, Erin G ^a   Lu, Kun ^a   Wishnok, John S ^a   Korzenik, Joshua R ^c   Wogan, Gerald N ^a,d   Fox, James G ^a,d   Dedon, Peter C ^a   Tannenbaum, Steven R ^a,d  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Granulocyte; Myeloperoxidase; Nitric oxide; Oxidative stress

Indexed keywords

3 NITROTYROSINE; 5 CHLORODEOXYCYTIDINE; BIOLOGICAL MARKER; CYTOKINE; DNA; PLASMA PROTEIN;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CHLORINATION; COLITIS; COLON; CROHN DISEASE; DISEASE COURSE; DNA DAMAGE; ENTERITIS; HELICOBACTER HEPATICUS; HUMAN; HUMAN TISSUE; INNATE IMMUNITY; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SERUM; ULCERATIVE COLITIS;

GRANULOCYTE; MYELOPEROXIDASE; NITRIC OXIDE; OXIDATIVE STRESS;

ACUTE-PHASE PROTEINS; ANIMALS; BIOLOGICAL MARKERS; CHEMOKINES; CYTOKINES; DEOXYCYTIDINE; DISEASE MODELS, ANIMAL; DNA DAMAGE; DNA-BINDING PROTEINS; FEMALE; HELICOBACTER HEPATICUS; HELICOBACTER INFECTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES; MALE; MICE; MICE, KNOCKOUT; TYROSINE;

HELICOBACTER HEPATICUS; MUS;

EID: 84879526786     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1222669110     Document Type: Article

References (70)

1. Danese S, Fiocchi C (2006) Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol 12(30):4807-4812.
2. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347(6):417-429.
3. Molodecky NA, et al. (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142(1): 46-54.e42; quiz e30.
4. Feagins LA, Souza RF, Spechler SJ (2009) Carcinogenesis in IBD: Potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol 6(5):297-305.
5. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883-899.
6. Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ; Sargramostim in Crohn's Disease Study Group (2005) Sargramostim for active Crohn's disease. N Engl J Med 352(21):2193-2201.
7. Reaves TA, et al. (2001) Neutrophil transepithelial migration: Regulation at the apical epithelial surface by Fc-mediated events. Am J Physiol Gastrointest Liver Physiol 280(4):G746-G754.
8. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A (2001) Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 159(6):2001-2009.
9. Erdman SE, et al. (2009) Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci USA 106(4):1027-1032.
10. Mangerich A, et al. (2012) Infection-induced colitis in mice causes dynamic and tissuespecific changes in stress response and DNA damage leading to colon cancer. Proc Natl Acad Sci USA 109(27):E1820-E1829.
11. McBee ME, et al. (2010) Multivariate modeling identifies neutrophil- and Th17- related factors as differential serum biomarkers of chronic murine colitis. PLoS ONE 5(10):e13277.
12. Erdman SE, et al. (2003) CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 162(2):691-702.
13. Maloy KJ, et al. (2003) CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197(1):111-119.
14. Hurst JK, Barrette WCJ, Jr. (1989) Leukocytic oxygen activation and microbicidal oxidative toxins. Crit Rev Biochem Mol Biol 24(4):271-328.
15. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320(6):365-376.
16. Naito Y, Takagi T, Yoshikawa T (2007) Neutrophil-dependent oxidative stress in ulcerative colitis. J Clin Biochem Nutr 41(1):18-26.
17. Klebanoff SJ, Belding ME (1974) Virucidal activity of H2O2-generating bacteria: Requirement for peroxidase and a halide. J Infect Dis 129(3):345-348.
18. Harrison JE, Schultz J (1976) Studies on the chlorinating activity of myeloperoxidase. J Biol Chem 251(5):1371-1374.
19. Pattison DI, Davies MJ (2006) Reactions of myeloperoxidase-derived oxidants with biological substrates: Gaining chemical insight into human inflammatory diseases. Curr Med Chem 13(27):3271-3290.
20. Winterbourn CC (2002) Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 181-182:223-227.
21. Domigan NM, Charlton TS, Duncan MW, Winterbourn CC, Kettle AJ (1995) Chlorination of tyrosyl residues in peptides bymyeloperoxidase and human neutrophils. J Biol Chem 270(28):16542-16548.
22. Gaut JP, et al. (2001) Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci USA 98(21):11961-11966.
23. Henderson JP, Byun J, Heinecke JW (1999) Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes produces 5-chlorocytosine in bacterial RNA. J Biol Chem 274(47):33440-33448.
24. Stanley NR, Pattison DI, Hawkins CL (2010) Ability of hypochlorous acid and N-chloramines to chlorinate DNA and its constituents. Chem Res Toxicol 23(7): 1293-1302.
25. Whiteman M, Jenner A, Halliwell B (1997) Hypochlorous acid-induced base modifications in isolated calf thymus DNA. Chem Res Toxicol 10(11):1240-1246.
26. Szabó C, Ischiropoulos H, Radi R (2007) Peroxynitrite: Biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6(8):662-680.
27. Lim CH, Dedon PC, Deen WM (2008) Kinetic analysis of intracellular concentrations of reactive nitrogen species. Chem Res Toxicol 21(11):2134-2147.
28. Klebanoff SJ (1993) Reactive nitrogen intermediates and antimicrobial activity: Role of nitrite. Free Radic Biol Med 14(4):351-360.
29. Eiserich JP, et al. (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391(6665):393-397.
30. Gaut JP, et al. (2002) Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest 109(10):1311-1319.
31. Gaut JP, Byun J, Tran HD, Heinecke JW (2002) Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry. Anal Biochem 300(2):252-259.
32. Hazen SL, Hsu FF, Mueller DM, Crowley JR, Heinecke JW (1996) Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest 98(6):1283-1289.
33. Leeuwenburgh C, et al. (1997) Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 272(3):1433-1436.
34. Brennan ML, et al. (2002) A tale of two controversies: Defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 277(20):17415-17427.
35. Kang JIJ, Jr., Neidigh JW (2008) Hypochlorous acid damages histone proteins forming 3-chlorotyrosine and 3,5-dichlorotyrosine. Chem Res Toxicol 21(5):1028-1038.
36. Marvin LF, et al. (2003) Quantification of o,o'-dityrosine, o-nitrotyrosine, and o-tyrosine in cat urine samples by LC/electrospray ionization-MS/MS using isotope dilution. Anal Chem 75(2):261-267.
37. Frost MT, Halliwell B, Moore KP (2000) Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. Biochem J 345(Pt 3):453-458.
38. Chen HJ, Row SW, Hong CL (2002) Detection and quantification of 5-chlorocytosine in DNA by stable isotope dilution and gas chromatography/ negative ion chemical ionization/mass spectrometry. Chem Res Toxicol 15(2):262-268.
39. Bergt C, et al. (2004) The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci USA 101(35):13032-13037.
40. Singer II, et al. (1996) Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111(4):871-885.
41. Keshavarzian A, et al. (2003) Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52(5):720-728.
42. Taghizadeh K, et al. (2008) Quantification of DNA damage products resulting from deamination, oxidation and reaction with products of lipid peroxidation by liquid chromatography isotope dilution tandem mass spectrometry. Nat Protoc 3(8): 1287-1298.
43. Zieske LR (2006) A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot 57(7):1501-1508.
44. Boulard O, Kirchberger S, Royston DJ, Maloy KJ, Powrie FM (2012) Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation. J Exp Med 209(7):1309-1324.
45. Hue S, et al. (2006) Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 203(11):2473-2483.
46. Cua DJ, Tato CM (2010) Innate IL-17-producing cells: The sentinels of the immune system. Nat Rev Immunol 10(7):479-489.
47. Lau KS, et al. (2012) Multi-scale in vivo systems analysis reveals the influence of immune cells on TNF-α-induced apoptosis in the intestinal epithelium. PLoS Biol 10(9): e1001393.
48. Raczynski AR, et al. (2012) Enteric infection with Citrobacter rodentium induces coagulative liver necrosis and hepatic inflammation prior to peak infection and colonic disease. PLoS ONE 7(3):e33099.
49. Uko V, Thangada S, Radhakrishnan K (2012) Liver disorders in inflammatory bowel disease. Gastroenterol Res Pract 2012:642923.
50. Kayo S, et al. (2006) Close association between activated platelets and neutrophils in the active phase of ulcerative colitis in humans. Inflamm Bowel Dis 12(8):727-735.
51. Fox JG, et al. (1996) Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: A model of helicobacter-induced carcinogenesis. Infect Immun 64(5):1548-1558.
52. Rogers AB, et al. (2004) Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice. Toxicol Pathol 32(6):668-677.
53. Ward JM, et al. (1994) Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 86(16):1222-1227.
54. Kang JIJ, Jr., Sowers LC (2008) Examination of hypochlorous acid-induced damage to cytosine residues in a CpG dinucleotide in DNA. Chem Res Toxicol 21(6):1211-1218.
55. Lao VV, et al. (2009) Incorporation of 5-chlorocytosine into mammalian DNA results in heritable gene silencing and altered cytosine methylation patterns. Carcinogenesis 30(5):886-893.
56. Valinluck V, Sowers LC (2007) Inflammation-mediated cytosine damage: A mechanistic link between inflammation and the epigenetic alterations in human cancers. Cancer Res 67(12):5583-5586.
57. Alex P, et al. (2009) Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis 15(3):341-352.
58. Buonocore S, et al. (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464(7293):1371-1375.
59. Sutton CE, et al. (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31(2): 331-341.
60. Arthur JC, et al. (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338(6103):120-123.
61. Devkota S, et al. (2012) Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487(7405):104-108.
62. Qian GS, et al. (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3(1):3-10.
63. Weeke B, Jarnum S (1971) Serum concentration of 19 serum proteins in Crohn's disease and ulcerative colitis. Gut 12(4):297-302.
64. Meuwis MA, et al. (2007) Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochem Pharmacol 73(9):1422-1433.
65. Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: Useful, magic, or unnecessary toys? Gut 55(3):426-431.
66. Lu K, Knutson CG, Wishnok JS, Fox JG, Tannenbaum SR (2012) Serum metabolomics in a Helicobacter hepaticus mouse model of inflammatory bowel disease reveal important changes in the microbiome, serum peptides, and intermediary metabolism. J Proteome Res 11(10):4916-4926.
67. Zhang X, et al. (2012) The potential role of ORM2 in the development of colorectal cancer. PLoS ONE 7(2):e31868.
68. Saha S, et al. (2010) Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma. Cell Host Microbe 8(2):147-162.
69. Colombel JF, et al.; SONIC Study Group (2010) Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 362(15):1383-1395.
70. Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9(5):313-323.